53.86
-1.35
(-2.45%)
As of 3:34:48 PM GMT+1. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 30 | 31 | 41 | 42 |
| Avg. Estimate | 7.84B | 8.09B | 32.95B | 35.08B |
| Low Estimate | 7.62B | 7.8B | 31.59B | 32.74B |
| High Estimate | 8.05B | 8.26B | 34.18B | 37.03B |
| Year Ago Sales | 7.7B | 7.88B | 31.8B | 32.95B |
| Sales Growth (year/est) | 1.77% | 2.62% | 3.64% | 6.46% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 2PPD.XC | -- | -- | -- | -- |
| S&P 500 | 6.76% | 5.73% | 9.19% | 14.14% |
Upgrades & Downgrades
| Maintains | Wells Fargo: Equal-Weight to Equal-Weight | 4/16/2025 |
| Maintains | Barclays: Overweight to Overweight | 4/15/2025 |
| Maintains | B of A Securities: Buy to Buy | 4/14/2025 |
| Initiated | Evercore ISI Group: In-Line | 4/9/2025 |
| Maintains | Monness, Crespi, Hardt: Buy to Buy | 4/8/2025 |
| Maintains | Morgan Stanley: Equal-Weight to Equal-Weight | 2/26/2025 |